Early Vaccination With Bacille Calmette-Guerin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial

被引:32
|
作者
Schaltz-Buchholzer, Frederik [1 ,2 ,3 ,4 ]
Bjerregaard-Andersen, Morten [3 ,4 ]
Oland, Christian Bjerregard [4 ]
Golding, Christian [3 ,4 ]
Stjernholm, Elise Brenno [3 ,4 ]
Monteiro, Ivan [3 ]
Aaby, Peter [3 ]
Benn, Christine Stabell [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[2] Odense Univ Hosp, Odense, Denmark
[3] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau
[4] Statens Serum Inst, Res Ctr Vitamins & Vaccines, Copenhagen, Denmark
[5] Univ Southern Denmark, Danish Inst Adv Sci, Odense, Denmark
基金
新加坡国家研究基金会;
关键词
BCG strains; early-life morbidity and mortality; tuberculosis; nonspecific effects of vaccines; purified protein derivative response; TUBERCULIN REACTION; IMMUNE-RESPONSE; SCAR; CHILDREN; MORTALITY; STRAINS; PROTECTION; MORBIDITY; INFANTS; COHORT;
D O I
10.1093/cid/ciz1080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Bacille Calmette-Guerin (BCG) vaccination remains a cornerstone against tuberculosis. Randomized controlled trials (RCTs) have demonstrated that BCG-Denmark lowers all-cause mortality, but a recent RCT found no effect of BCG-Russia. Observational studies indicate that the genetically divergent BCG strains have different effects. Methods. This was a parallel-group, open-label RCT conducted at the National IIospital in Guinea-Bissau. Healthy neonates were randomized 1:1 to BCG-Denmark (2851 randomized, 2840 analyzed) vs BCG-Russia (2845 randomized, 2837 analyzed). We hypothesized that BCG-Denmark would reduce morbidity (primary outcome) and mortality while inducing more BCG reactions and purified protein derivative (PPD) responses (secondary outcomes). Halfway through the trial, production of BCG-Denmark was halted, and the trial continued comparing BCG-Japan (3191 neonates randomized, 3184 analyzed) with BCG-Russia (3170 randomized, 3160 analyzed). Mortality and morbidity data were collected by telephone, at home visits, and at the National Hospital and assessed in Cox models providing 6-week mortality rate ratios (MRRs) and hospitalization incidence rate ratios (IRRs). Results. By age 6 weeks, there were 140 and 130 admissions among neonates vaccinated with BCG-Denmark and BCG-Russia, respectively (IRR, 1.08 [95% confidence interval {CI}, .84-1.37]). For BCG-Japan, there were 185 admissions vs 161 admissions for BCG-Russia (IRR, 1.15 [95% CI, .93-1.43]). The 6-week mortality did not differ: BCG-Denmark/BCG-Russia (MRR, 1.15 [95% CI, .74-1.80]); BCG-Japan/BCG-Russia (MRR, 0.71 [95% CI, .43-1.19]). BCG-Denmark and BCG-Japan induced more BCG scars and PPD reactions than BCG-Russia. Conclusions. BCG strains did not affect morbidity. BCG-Denmark and BCG-Japan were more immunogenic than BCG-Russia by the measures traditionally viewed as surrogates for successful immunization. The implications of strain differences for tuberculosis protection and overall health warrant further study.
引用
收藏
页码:1883 / 1893
页数:11
相关论文
共 14 条
  • [1] Effects of Neonatal BCG-Japan Versus BCG-Russia Vaccination on Overall Mortality and Morbidity: Randomized Controlled Trial From Guinea-Bissau (BCGSTRAIN II)
    Schaltz-Buchholzer, Frederik
    Nielsen, Sebastian
    Sorensen, Marcus Kjaer
    Stjernholm, Elise Brenno
    Fabricius, Rebecca Alison
    Umbasse, Paulo
    Monteiro, Ivan
    Ca, Elsi Jose Carlos
    Aaby, Peter
    Benn, Christine Stabell
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (03):
  • [2] Can earlier BCG-Japan and OPV vaccination reduce early infant mortality? A cluster-randomised trial in Guinea-Bissau
    Thysen, Sanne Marie
    Borges, Igualdino da Silva
    Martins, Jailson
    Stjernholm, Alexander Dahl
    Hansen, Jesper Sloth
    da Silva, Leontino Manuel Vieira
    Martins, Justiniano Sebastiao Durga
    Jensen, Aksel
    Rodrigues, Amabelia
    Aaby, Peter
    Benn, Christine Stabell
    Fisker, Ane Baerent
    BMJ GLOBAL HEALTH, 2024, 9 (02):
  • [3] Immediate Bacille Calmette-Guerin Vaccination to Neonates Requiring Perinatal Treatment at the Maternity Ward in Guinea-Bissau: A Randomized Controlled Trial
    Schaltz-Buchholzer, Frederik
    Aaby, Peter
    Monteiro, Ivan
    Camala, Luis
    Simonsen, Simone Faurholt
    Frankel, Hannah Nortoft
    Larsen, Kristina Lindberg
    Golding, Christian N.
    Kollmann, Tobias R.
    Amenyogbe, Nelly
    Benn, Christine Stabell
    Bjerregaard-Andersen, Morten
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (11): : 1935 - 1944
  • [4] Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial
    Jensen, Kristoffer Jarlov
    Larsen, Nanna
    Biering-Sorensen, Sofie
    Andersen, Andreas
    Eriksen, Helle Brander
    Monteiro, Ivan
    Hougaard, David
    Aaby, Peter
    Netea, Mihai G.
    Flanagan, Katie L.
    Benn, Christine Stabell
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (06): : 956 - 967
  • [5] Early BCG Vaccination, Hospitalizations, and Hospital Deaths: Analysis of a Secondary Outcome in 3 Randomized Trials from Guinea-Bissau
    Schaltz-Buchholzer, Frederik
    Biering-Sorensen, S.
    Lund, N.
    Monteiro, I.
    Umbasse, P.
    Fisker, A. B.
    Andersen, A.
    Rodrigues, A.
    Aaby, P.
    Benn, C. S.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (04): : 624 - 632
  • [6] No adverse events after simultaneous administration of 50000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau
    Nante, J. E.
    Diness, B. R.
    Ravn, H.
    Roth, A.
    Aaby, P.
    Benn, C. S.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (07) : 842 - 848
  • [7] Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau
    Thysen, Sanne M.
    Jensen, Aksel Karl Georg
    Rodrigues, Amabelia
    Borges, Igualdino da Silva
    Aaby, Peter
    Benn, Christine
    Fisker, Ane
    BMJ OPEN, 2019, 9 (09):
  • [8] No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau
    J E Nante
    B R Diness
    H Ravn
    A Roth
    P Aaby
    C S Benn
    European Journal of Clinical Nutrition, 2008, 62 : 842 - 848
  • [9] Revisiting the Heterogeneous IFN-γ Response of Bacille of Calmette-Guerin (BCG)Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the IFNG+874 A/T Polymorphism
    Conceicao, Elisabete L.
    Nascimento-Sampaio, Francisco S.
    Schwingel, Paulo A.
    Oliveira, Evelin S.
    Rocha, Michael S.
    Vieira, Igor
    Mendes, Carlos M. C.
    Souza-Machado, Adelmir
    Oliveira, Martha M.
    Barral-Netto, Manoel
    Marinho, Jamocyr M.
    Barbosa, Theolis
    PLOS ONE, 2016, 11 (07):
  • [10] Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial
    Nankabirwa, Victoria
    Tumwine, James K.
    Namugga, Olive
    Tylleskar, Thorkild
    Ndeezi, Grace
    Robberstad, Bjarne
    Netea, Mihai G.
    Sommerfelt, Halvor
    TRIALS, 2017, 18